Anmelden Kostenlos registrieren

Novabay Pharmaceuticals Inc RPE

Was ist das RPE von Novabay Pharmaceuticals Inc?

RPE von Novabay Pharmaceuticals Inc ist $214.696k

Was ist die Definition von RPE?

Umsatz pro Mitarbeiter (RPE) ist der Umsatz geteilt durch die Anzahl der Mitarbeiter einer Organisation.

RPE von Unternehmen in Health Care Sektor auf NYSEMKT im Vergleich zu Novabay Pharmaceuticals Inc

Was macht Novabay Pharmaceuticals Inc?

novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across

Unternehmen mit rpe ähnlich Novabay Pharmaceuticals Inc